Skip to main content

Table 7 Mean per patient costs

From: Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

  Strategy 1 Strategy 2
Pharmaceutical cost €2853 €2427
Comorbidities costs €4393 €4539
Ischaemic heart disease cost €371 € 343
Myocardial infarction cost €1235 €1242
Congestive heart failure cost €340 €316
Stroke cost €1168 €1186
Amputation cost €36 €30
Renal failure cost €1243 €1422
Adverse events costs €2757 €3111
Non-severe hypoglycemia cost €19 €29
Severe hypoglycemia cost €126 €179
Monitoring costs €2611 €2903
Total costs €10,003 €10,077